GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Net Issuance of Debt

Endo (NDOI) Net Issuance of Debt : $2,496 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Endo Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Endo's net issuance of debt for the three months ended in Dec. 2024 was $0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2024 was $2,496 Mil.


Endo Net Issuance of Debt Historical Data

The historical data trend for Endo's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Net Issuance of Debt Chart

Endo Annual Data
Trend Dec22 Dec23 Dec24
Net Issuance of Debt
-503.45 -6.73 -

Endo Quarterly Data
Jun23 Sep23 Dec23 Apr24 Sep24 Dec24
Net Issuance of Debt Get a 7-Day Free Trial -1.70 -1.73 2,497.62 - -

Endo Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,496 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Endo Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Endo's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo Business Description

Traded in Other Exchanges
N/A
Address
9 Great Valley Parkway, Malvern, PA, USA, 19355
Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.